Healthcare dominates premarket gainers as Coronavirus gain 
 NanoViricides NNVC   as Coronavirus-related stocks up again as contagion spreads.

Akari Therapeutics, Plc (NASDAQ:AKTX)  on announcing preclinical ophthalmic data showing Nomacopan reduces both vascular endothelial growth factor and retinal inflammation supporting Nomacopan as a potential treatment option for back-of-the-eye diseases.